Drug firm Malin scraps plans for dual London listing

State-backed drug development investment firm Malin has scrapped plans to seek a secondary stock market listing in London.

Drug firm Malin scraps plans for dual London listing

By Geoff Percival

State-backed drug development investment firm Malin has scrapped plans to seek a secondary stock market listing in London.

Already a subscriber? Sign in

You have reached your article limit.

Subscribe to access all of the Irish Examiner.

Annual €130 €80

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited